BioLASCO Taiwan Co., Ltd. (6662.TWO)
TWD 33.1
(-3.22%)
TWD 33.1
(-3.22%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 111.98 Million TWD | -2.67% |
| 2022 | 115.05 Million TWD | 1.01% |
| 2021 | 113.9 Million TWD | -6.33% |
| 2020 | 121.59 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 101.3 Million TWD | -9.54% |
| 2024 Q2 | 189.34 Million TWD | 86.92% |
| 2023 Q4 | 111.98 Million TWD | 0.99% |
| 2023 FY | 111.98 Million TWD | -2.67% |
| 2023 Q2 | 140.7 Million TWD | 36.14% |
| 2023 Q3 | 110.88 Million TWD | -21.2% |
| 2023 Q1 | 103.35 Million TWD | 0.0% |
| 2022 Q4 | - TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -1501.101% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 80.808% |
| Level Biotechnology Inc. | 273.2 Million TWD | 59.011% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 18.751% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 43.292% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 91.567% |
| GlycoNex Incorporation | 276.39 Million TWD | 59.486% |
| VBI | 21.25 Million TWD | -426.945% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 64.304% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 78.241% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -427.565% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 69.598% |
| Visgeneer Inc. | 185.6 Million TWD | 39.667% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 91.537% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 84.723% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 6.574% |
| Neith Corporation | 17.43 Million TWD | -542.351% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 95.014% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -1592.067% |
| Enimmune corporation | 173.46 Million TWD | 35.444% |
| TaiRx, Inc. | 60.62 Million TWD | -84.711% |
| CHO Pharma, Inc. | 110.83 Million TWD | -1.037% |
| EirGenix Inc. | 1.14 Billion TWD | 90.221% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 78.147% |
| Lin BioScience, Inc. | 167.73 Million TWD | 33.237% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -19.492% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -77.652% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 10.221% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 30.472% |
| RBC Bioscience Corporation | 513.08 Million TWD | 78.175% |
| BiOptic Inc. | 170.56 Million TWD | 34.346% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -165.622% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -381.535% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -317.637% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 88.51% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -1304.679% |
| NaviFUS Corp. | 53.4 Million TWD | -109.698% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 76.743% |
| Sinew Pharma Inc. | 39.71 Million TWD | -181.969% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -92.941% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 69.276% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 50.82% |
| AP Biosciences Inc | 106.65 Million TWD | -4.999% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 96.828% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -264.985% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 42.864% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 92.744% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 87.076% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -1107.212% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -100.636% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 51.931% |
| TCI GENE Inc. | 155.54 Million TWD | 28.009% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -339.003% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -142.514% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 65.908% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -72.578% |
| PharmaEngine, Inc. | 91 Million TWD | -23.048% |
| Savior Lifetec Corporation | 457.95 Million TWD | 75.548% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -0.938% |
| OBI Pharma, Inc. | 650.44 Million TWD | 82.784% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 71.347% |
| Acepodia, Inc. | 384.47 Million TWD | 70.874% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -30.891% |